• Skip to main content
  • Skip to primary navigation
  • Home
  • Community Schedule
  • Hospital Medicines (HML)
  • Medicine funding application status

Pharmac - Te Pātaka Whaioranga. Pharmac - Te Pātaka Whaioranga. Pharmac - Te Pātaka Whaioranga.

  • Te Rārangi Rongoā Pharmaceutical Schedule

    Pharmaceutical Schedule

    All funded medicines in New Zealand.

    • Community Schedule

    • Practitioners supply order (PSO)

    • Extemporaneously compounded products and galenicals

    • Hospital Medicines (HML)

    • Schedule Updates

    • Schedule resources

    • About the Schedule

    • Rules of the Schedule

    • Hospital Medical Devices

  • Te pūtea me ngā umanga rongoā Medicine funding and supply

    Medicine funding and supply

    Ask us to fund a medicine | Check changes to medicines | How do generics work?

    • Make an application

    • Medicine notices (includes supply issues)

      Brand changes, discontinuations and more.

    • The funding process

    • What you need to know about medicines

    • Medicine supply management

      Order condoms and nicotine replacement | About supply management

    • Progress to funding cancer and other medicines

  • Ngā pūrere hauora a te hōhipere Hospital medical devices

    Hospital medical devices

    • The hospital medical devices programme

    • Using the Hospital Medical Devices List

    • Getting devices onto the Hospital Medical Devices List

    • Category Information

      Medical devices we have contracted and the ones we're working on

    • Hospital Medical Devices List

      Download the latest hospital medical devices schedule

    • Hospital medical device supply management

    • The future of hospital medical device management

    • Device Advice

      Read and subscribe to our devices newsletter

  • Treaty of Waitangi Te Tiriti o Waitangi

    Te Tiriti o Waitangi

    • Te Tiriti o Waitangi policy

      Pharmac's Te Tiriti o Waitangi Policy came into effect in November 2022.

    • Te Whaioranga

      Te Pātaka Whaioranga's Māori Responsiveness Strategy

    • Hauora Arotahi

      The Māori health areas of focus

    • How we work with Whānau Ora

  • Ngā karere me ngā rauemi News and resources

    News and resources

    • Consultations and decisions

      includes RFPs and tenders.

    • News, stories, and updates

    • Official information releases

      How to make an OIA or Privacy Act request and find information Pharmac has already released.

    • Publications and resources

    • Continuous glucose monitors (CGMs) and insulin pumps

      Funded from 1 October 2024 for eligible people. Find out who qualifies and what is funded.

    • COVID-19

    • Pharmac's research

  • Mō About

    About

    • Strategic Direction

      Our plan to deliver the best health outcomes for New Zealanders

    • Access equity

      Our work to improve equity of access to medicines in New Zealand.

    • The Pharmac Review

    • What we do

    • Who we are

    • How we get expert advice

      Advice we seek to make decisions

    • Working at Pharmac

      Explore current vacancies

    • Contact us

      How to get in touch

  1. Home
  2. News and resources
  3. COVID-19
  4. Access criteria for COVID-19 medicines

Access criteria for COVID-19 medicines

These funding criteria are updated regularly in response to the need and availability of the medicines.

  • COVID-19 antivirals: Access Criteria

    Access criteria for nirmatrelvir with ritonavir (Paxlovid), and remdesivir (Veklury)

  • Tixagevimab with cilgavimab (Evusheld) Access Criteria

  • Access criteria for treatments for persistent SARS-CoV-2 infection

  • Molnupiravir access criteria

  • Severely immunocompromised for access to COVID-19 antiviral treatments

  • Identifying people at high risk for severe illness from COVID-19

Back to top

Pharmac - Te Pātaka Whaioranga.

  • Community Schedule
  • Hospital Medicines (HML)
  • Application Tracker
  • Contact us
  • Follow us
  • Facebook
  • LinkedIn
  • Twitter

Shielded site.

  • Copyright
  • Disclaimer
  • Privacy statement
  • Subscribe
  • Media centre

New Zealand Government.